Invariant NKT cell regulation of autoimmunity

Alberto Molano, Steven A. Porcelli

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Accumulating evidence supports the notion that invariant NKT cells that recognize glycolipids presented by CD1d can play a role in the regulation of certain types of autoimmunity. Focusing mainly on studies of type 1 diabetes and several other common autoimmune diseases, we present an overview of the available knowledge and current speculations on the immunoregulatory mechanisms of NKT cells. Targeting invariant NKT cells with specific glycolipids that bind to CD1d might prove to be a powerful means of modulating autoimmunity.

Original languageEnglish (US)
Pages (from-to)193-198
Number of pages6
JournalDrug Discovery Today: Disease Mechanisms
Volume3
Issue number2
DOIs
StatePublished - Sep 15 2006

    Fingerprint

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this